Alfredo Caturano

Non-Alcoholic Fatty Liver Disease: From Pathogenesis to Clinical Impact

Alfredo Caturano, Carlo Acierno, Riccardo Nevola et al. · Processes · 2021 · 102 citations · Full text

Metabolic Disorder, Pathology, Fatty Liver Disease +22

The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial

Ferdinando Carlo Sasso, Vittorio Simeon, Raffaele Galiero et al. · Cardiovascular Diabetology · 2022 · 72 citations · Full text

High HDL cholesterol: A risk factor for diabetic retinopathy? Findings from NO BLIND study

Ferdinando Carlo Sasso, Pia Clara Pafundi, Aldo Gelso et al. · Diabetes Research and Clinical Practice · 2019 · 70 citations

Metabolic Syndrome, Diabetic Retinopathy, No Blind Study +10

Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coin

Carlo Acierno, Alfredo Caturano, Pia Clara Pafundi et al. · Exploration of Medicine · 2020 · 63 citations · Full text

Pathology, Fatty Liver Disease, Insulin Signaling +26

Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes

Ferdinando Carlo Sasso, Pia Clara Pafundi, Alfredo Caturano et al. · Nutrition Metabolism and Cardiovascular Diseases · 2021 · 53 citations

Cardiovascular Disease, Diabetes, Antiviral Drug Development +10